XML 47 R21.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Shareholders' Equity Note 12—Shareholders' Equity
Share Data: A summary of common share activity is presented in the following chart.
Common Stock
IssuedTreasury
Stock
2019:
Balance at January 1, 2019121,218,183 (10,525,147)
Grants of restricted stock— 8,840 
Vesting of performance shares— 311,399 
Issuance of common stock due to exercise of stock options— 1,810,559 
Treasury stock acquired— (5,103,591)
Retirement of treasury stock(4,000,000)4,000,000 
Balance at December 31, 2019
117,218,183 (9,497,940)
2020:
Grants of restricted stock— 4,548 
Vesting of performance shares— 271,843 
Issuance of common stock due to exercise of stock options— 936,289 
Treasury stock acquired— (5,135,439)
Retirement of treasury stock(4,000,000)4,000,000 
Balance at December 31, 2020
113,218,183 (9,420,699)
2021:
Grants of restricted stock— 10,031 
Vesting of performance shares— 210,155 
Issuance of common stock due to exercise of stock options— 1,191,704 
Treasury stock acquired— (5,642,036)
Retirement of treasury stock(4,000,000)4,000,000 
Balance at December 31, 2021
109,218,183 (9,650,845)

There was no activity related to the preferred stock in years 2019 through 2021.
Acquisition of Common Shares: Globe Life shares are acquired through open market purchases under the Globe Life stock repurchase program when it is determined to be the best use of Globe Life's excess cash flows. This yields a return that is better than available alternatives and exceeds our cost of equity. When stock options are exercised, proceeds from the exercises are generally used to repurchase approximately the number of shares available with those funds in order to reduce dilution. See the following summary below:
Globe Life Share Repurchase ProgramShare Repurchase for Dilution Purposes
Shares Acquired
(in thousands)
Total CostAverage PriceShares Acquired
(in thousands)
Total CostAverage Price
2021
4,784 $455,030 $95.11 858 $86,405 $100.75 
2020
4,459 380,112 85.24 676 63,754 94.28 
2019
3,932 350,080 89.04 1,209 109,489 90.52 
Restrictions: Restrictions exist on the flow of funds to Globe Life Inc. from its insurance subsidiaries. Statutory regulations require life insurance subsidiaries to maintain certain minimum amounts of capital and surplus. Dividends from insurance subsidiaries of Globe Life Inc. are restricted based on regulations by their states of domicile. Additionally, insurance company distributions are generally not permitted in excess of statutory surplus. Subsidiaries are also subject to certain minimum capital requirements. Subsidiaries of Globe Life paid cash dividends to the Parent Company in the amount of $479 million in 2021, $486 million in 2020, and $480 million in 2019. As of December 31, 2021, dividends from insurance subsidiaries to the Parent Company available to be paid in 2022 are limited to the amount of $347 million without regulatory approval, such that $1.2 billion was considered restricted net assets of the subsidiaries. Dividends exceeding these limitations may be available during the year pending regulatory approval. While there are no legal restrictions on the payment of dividends to shareholders from Globe Life's retained earnings, retained earnings as of December 31, 2021, were restricted by lenders’ covenants which require the Company to maintain and not distribute $4.3 billion from its total consolidated retained earnings of $6.2 billion.
Earnings per Share: A reconciliation of basic and diluted weighted-average shares outstanding used in the computation of basic and diluted earnings per share is as follows:
Year Ended December 31,
202120202019
Basic weighted average shares outstanding102,069,781 106,075,267 109,213,524 
Weighted average dilutive options outstanding1,100,351 1,149,327 2,167,726 
Diluted weighted average shares outstanding103,170,132 107,224,594 111,381,250 
Antidilutive shares2,412,884 2,476,019 21,556 

Antidilutive shares are excluded from the calculation of diluted earnings per share. All antidilutive shares noted above result from outstanding out of the money employee and Director stock options.